UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98,637 | -71.0% | 14,700 | -2.0% | 0.00% | -75.0% |
| Q4 2022 | $340,050 | -47.9% | 15,000 | -56.9% | 0.00% | -42.9% |
| Q3 2022 | $652,848 | -17.9% | 34,800 | -20.9% | 0.01% | 0.0% |
| Q1 2022 | $795,000 | +86.2% | 44,000 | +113.6% | 0.01% | +133.3% |
| Q4 2021 | $427,000 | -1.8% | 20,600 | +51.5% | 0.00% | -25.0% |
| Q3 2021 | $435,000 | +75.4% | 13,600 | +147.3% | 0.00% | +33.3% |
| Q2 2020 | $248,000 | -22.0% | 5,500 | -17.9% | 0.00% | -25.0% |
| Q1 2020 | $318,000 | – | 6,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |